Peptides and antibodies that inhibit integrin-ligand bindin g
CA 2000048 A1 · Owner: Ginsberg, Mark H. · Inventors: Ginsberg, Mark H.; D'Souza, Stanley E.; Plow, Edward F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Polypeptides which are derived from the Arg-Gly- Asp (RGD) binding portion of an Integrin beta subunit are disclosed as are their use for modulation of Integrin ligand binding. Anti-peptide antibodies hybridomas, secreting these antibodies as well as methods of making, and using such antibodies and recombinant DNA molecules, that define the structural gene coding for the polypeptides are also contemplated as within the scope of the present invention.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 2, 1989. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 2, 2009.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 2, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.